|
1
|
S BlagdenJ de BonoDrugging cell cycle
kinases in cancer therapyCurr Drug
Targets6325335200510.2174/138945005376582415857291
|
|
2
|
KH ChangY de PabloHP LeeHG LeeMA SmithK
ShahCdk5 is a major regulator of p38 cascade: relevance to
neurotoxicity in Alzheimer's diseaseJ
Neurochem11312211229201020345761
|
|
3
|
LM SchangAdvances on cyclin-dependent
kinases (CDKs) as novel targets for antiviral drugsCurr Drug
Targets Infect Disord52937200510.2174/156800505317460915777196
|
|
4
|
J CicenasM ValiusThe CDK inhibitors in
cancer research and therapyJ Cancer Res Clin
Oncol13714091418201110.1007/s00432-011-1039-421877198
|
|
5
|
H IsekiTC KoXY XueA SeapanMR HellmichCM
Townsend JrCyclin-dependent kinase inhibitors block proliferation
of human gastric cancer
cellsSurgery122187195199710.1016/S0039-6060(97)90008-89288122
|
|
6
|
L MeijerA BorgneO MulnerBiochemical and
cellular effects of roscovitine, a potent and selective inhibitor
of the cyclin-dependent kinases cdc2, cdk2 and cdk5Eur J
Biochem243527536199710.1111/j.1432-1033.1997.t01-2-00527.x
|
|
7
|
B SchutteL NielandM van EngelandME
HenflingL MeijerFC RamaekersThe effect of the cyclin-dependent
kinase inhibitor olomoucine on cell cycle kineticsExp Cell
Res236415199710.1006/excr.1997.37009344580
|
|
8
|
J Wesierska-GadekSB HajekB SargS WandlE
WalziH LindnerPleiotropic effects of selective CDK inhibitors on
human normal and cancer cellsBiochem
Pharmacol7615031514200810.1016/j.bcp.2008.07.04018761330
|
|
9
|
T David-PfeutyPotent inhibitors of
cyclin-dependent kinase 2 induce nuclear accumulation of wild-type
p53 and nucleolar fragmentation in human untransformed and
tumor-derived cellsOncogene1874097422199910.1038/sj.onc.1203103
|
|
10
|
MV AppleyardMA O'NeillKE MurraySeliciclib
(CYC202, R-roscovitine) enhances the antitumor effect of
doxorubicin in vivo in a breast cancer xenograft modelInt J
Cancer124465472200910.1002/ijc.2393819003963
|
|
11
|
G Ortiz-FerronR YerbesA EramoAI
Lopez-PerezR de MariaA Lopez-RivasRoscovitine sensitizes breast
cancer cells to TRAIL-induced apoptosis through a pleiotropic
mechanismCell Res18664676200810.1038/cr.2008.54
|
|
12
|
J Wesierska-GadekMP KramerM
MaurerResveratrol modulates roscovitine-mediated cell cycle arrest
of human MCF-7 breast cancer cellsFood Chem
Toxicol4613271333200810.1016/j.fct.2007.09.00417933449
|
|
13
|
F ZhangT ZhangZP GuEnhancement of
radiosensitivity by roscovitine pretreatment in human non-small
cell lung cancer A549 cellsJ Radiat Res
(Tokyo)49541548200810.1269/jrr.0802418728343
|
|
14
|
S MohapatraB ChuX ZhaoJ DjeuJQ ChengWJ
PledgerApoptosis of metastatic prostate cancer cells by a
combination of cyclin-dependent kinase and AKT inhibitorsInt J
Biochem Cell
Biol41595602200910.1016/j.biocel.2008.07.01318708158
|
|
15
|
M MaurerO KominaJ
Wesierska-GadekRoscovitine differentially affects asynchronously
growing and synchronized human MCF-7 breast cancer cellsAnn NY Acad
Sci1171250256200910.1111/j.1749-6632.2009.04717.x19723062
|
|
16
|
JD ZolnierczykJZ BlonskiT RobakZM
KilianskaJ Wesierska-GadekRoscovitine triggers apoptosis in B-cell
chronic lymphocytic leukemia cells with similar efficiency as
combinations of conventional purine analogs with
cyclophosphamideAnn NY Acad
Sci1171124131200910.1111/j.1749-6632.2009.04903.x
|
|
17
|
D IizukaO InanamiI KashiwakuraM
KuwabaraPurvalanol A enhances cell killing by inhibiting
up-regulation of CDC2 kinase activity in tumor cells irradiated
with high doses of X raysRadiat
Res167563571200710.1667/RR0622.117474786
|
|
18
|
L CerquettiC SampaoliD AmendolaMitotane
sensitizes adrenocortical cancer cells to ionizing radiations by
involvement of the cyclin B1/CDK complex in G2 arrest and mismatch
repair enzymes modulationInt J Oncol374935012010
|
|
19
|
T HikitaC OneyamaM OkadaPurvalanol A, a
CDK inhibitor, effectively suppresses Src-mediated transformation
by inhibiting both CDKs and c-SrcGenes
Cells1510511062201010.1111/j.1365-2443.2010.01439.x20825494
|
|
20
|
PM PriceF YuP KaldisDependence of
cisplatin-induced cell death in vitro and in vivo on
cyclin-dependent kinase 2J Am Soc
Nephrol1724342442200610.1681/ASN.200602016216914540
|
|
21
|
D IizukaA OguraM KuwabaraO
InanamiPurvalanol A induces apoptosis and downregulation of
antiapoptotic proteins through abrogation of phosphorylation of
JAK2/STAT3 and RNA polymerase IIAnticancer
Drugs19565572200810.1097/CAD.0b013e3282fe330e18525315
|
|
22
|
M PennatiAJ CampbellM CurtoPotentiation of
paclitaxel-induced apoptosis by the novel cyclin-dependent kinase
inhibitor NU6140: a possible role for survivin down-regulationMol
Cancer Ther413281337200510.1158/1535-7163.MCT-05-002216170024
|
|
23
|
VM YenugondaTB DebSC GrindrodFluorescent
cyclin-dependent kinase inhibitors block the proliferation of human
breast cancer cellsBioorg Med
Chem1927142725201110.1016/j.bmc.2011.02.05221440449
|
|
24
|
L RingerP SirajuddinVM YenugondaVMY-1–103,
a dansylated analog of purvalanol B, induces caspase-3-dependent
apoptosis in LNCaP prostate cancer cellsCancer Biol
Ther103203252010
|
|
25
|
LJ MartonAE PeggPolyamines as targets for
therapeutic interventionAnnu Rev Pharmacol
Toxicol355591199510.1146/annurev.pa.35.040195.0004157598507
|
|
26
|
LJ MartonAE PeggDR MorrisDirections for
polyamine researchJ Cell
Biochem4578199110.1002/jcb.2404501052005186
|
|
27
|
G AnderssonO HebyKinetics of cell
proliferation and polyamine synthesis during Ehrlich ascites tumor
growthCancer Res37436143661977922727
|
|
28
|
O HebyG AnderssonJW GrayInterference with
S and G2 phase progression by polyamine synthesis inhibitorsExp
Cell Res111461464197810.1016/0014-4827(78)90192-1627248
|
|
29
|
U BachrachPolyamines as chemical markers
of malignancyItal J Biochem2577931976773897
|
|
30
|
MG MontiL PerneccoR ManfrediniInhibition
of cell growth by accumulated spermine is associated with a
transient alteration of cell cycle progressionLife
Sci5820652072199610.1016/0024-3205(96)00200-78649191
|
|
31
|
Y WangRA Casero JrMammalian polyamine
catabolism: a therapeutic target, a pathological problem, or both?J
Biochem1391725200610.1093/jb/mvj02116428315
|
|
32
|
RA CaseroAE PeggPolyamine catabolism and
diseaseBiochem J421323338200910.1042/BJ2009059819589128
|
|
33
|
Y HuangA PledgieRA Casero JrNE
DavidsonMolecular mechanisms of polyamine analogs in cancer
cellsAnticancer
Drugs16229241200510.1097/00001813-200503000-0000215711175
|
|
34
|
Y ChenRS WeeksMR BurnsDW BoormanA
Klein-SzantoTG O'BrienCombination therapy with
2-difluoromethylornithine and a polyamine transport inhibitor
against murine squamous cell carcinomaInt J
Cancer11823442349200610.1002/ijc.2162116331620
|
|
35
|
MR BurnsGF GraminskiRS WeeksY ChenTG
O'BrienLipophilic lysine-spermine conjugates are potent polyamine
transport inhibitors for use in combination with a polyamine
biosynthesis inhibitorJ Med Chem5219831993200910.1021/jm801580w
|
|
36
|
L MyhreK AlmC HegardtDifferent cell cycle
kinetic effects of N1,N11-diethylnorspermine-induced polyamine
depletion in four human breast cancer cell linesAnticancer
Drugs19359368200810.1097/CAD.0b013e3282f7f51818454046
|
|
37
|
K DredgeJA KinkRM JohnsonI BythewayLJ
MartonThe polyamine analog PG11047 potentiates the antitumor
activity of cisplatin and bevacizumab in preclinical models of lung
and prostate cancerCancer Chemother
Pharmacol65191195200910.1007/s00280-009-1105-719685053
|
|
38
|
S HectorR TummalaND KisielPolyamine
catabolism in colorectal cancer cells following treatment with
oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermineCancer
Chemother
Pharmacol62517527200810.1007/s00280-007-0633-217987291
|
|
39
|
WL AllenEG McLeanJ BoyerThe role of
spermidine/spermine N1-acetyltransferase in determining response to
chemotherapeutic agents in colorectal cancer cellsMol Cancer
Ther6128137200710.1158/1535-7163.MCT-06-030317237273
|
|
40
|
N BabbarEW GernerRA Casero JrInduction of
spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in
Caco-2 colon cancer cellsBiochem
J394317324200610.1042/BJ2005129816262603
|
|
41
|
ED ArisanA CokerN Palavan-UnsalPolyamine
depletion enhances the roscovitine-induced apoptosis through the
activation of mitochondria in HCT116 colon carcinoma cellsAmino
AcidsAug22011(E-pub ahead of print).
|
|
42
|
OM TiradoS Mateo-LozanoV
NotarioRoscovitine is an effective inducer of apoptosis of Ewing's
sarcoma family tumor cells in vitro and in vivoCancer
Res6593209327200510.1158/0008-5472.CAN-05-127616230394
|
|
43
|
R VarmaS HectorWR GrecoPlatinum drug
effects on the expression of genes in the polyamine pathway:
time-course and concentration-effect analysis based on Affymetrix
gene expression profiling of A2780 ovarian carcinoma cellsCancer
Chemother
Pharmacol59711723200710.1007/s00280-006-0325-317021820
|
|
44
|
A PledgieY HuangA HackerSpermine oxidase
SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary
source of cytotoxic H2O2 in polyamine
analogue-treated human breast cancer cell linesJ Biol
Chem2803984339851200516207710
|
